All data are based on the daily closing price as of August 12, 2025
v
Vital KSK Holdings
3151.TSE
8.52 USD
-0.02
-0.23%
Overview
Last close
8.52 usd
Market cap
412.04M usd
52 week high
9.70 usd
52 week low
7.07 usd
Target price
N/A usd
Valuation
P/E
8.4737
Forward P/E
N/A
Price/Sales
0.1014
Price/Book Value
0.5849
Enterprise Value
290.59M usd
EV/Revenue
0.0718
EV/EBITDA
2.962
Key financials
Revenue TTM
4.06B usd
Gross Profit TTM
332.78M usd
EBITDA TTM
61.79M usd
Earnings per Share
1 usd
Dividend
0.3 usd
Total assets
2.01B usd
Net debt
-97.30M usd
About
Vital KSK Holdings, Inc. engages in the wholesale and retail sale of pharmaceutical products in Japan. It operates through Pharmaceutical Wholesale Business; Pharmacy Business; Veterinary Drug Wholesale Business; and Other Businesses. The company is involved in the nursing care; agrochemical wholesale; and sale of pharmaceuticals, poisonous or deleterious substances, narcotics, quasi-drugs, vaccines, paints, pigments, dyes, medical equipment, sanitary materials, hygiene goods, nursing care products, and beverages. It also engages in the medical and pharmacy consulting business; general freight vehicle transportation; and insurance agency, real estate management, and parking lot operation. Vital KSK Holdings, Inc. was incorporated in 2009 and is headquartered in Setagaya, Japan.